Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB23FYQ95
Awardee
Awarding agency
Obligated
$77,370

Award facts

Contract value 100% obligated
$77,370.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of performance. No major subcontractors or set aside designations were identified in the award information.

Quick answers

Who was awarded contract SPE2DB23FYQ95?

SPE2DB23FYQ95 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2023.

How much is contract SPE2DB23FYQ95 worth?

The government has obligated $77,370 on SPE2DB23FYQ95.

Is contract SPE2DB23FYQ95 an order under another contract?

Yes. SPE2DB23FYQ95 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.

Was contract SPE2DB23FYQ95 competed?

The extent of competition for SPE2DB23FYQ95 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award